share_log

IMAC Holdings, Inc. Receives Nasdaq Deficiency Notification for Late 10-Q Filing

IMAC Holdings, Inc. Receives Nasdaq Deficiency Notification for Late 10-Q Filing

IMAC控股公司收到納斯達克關於遲交10-Q報告的缺陷通知
Quiver Quantitative ·  11/23 06:20

IMAC Holdings received a Nasdaq notification for failing to file its Q3 report on time, seeking compliance by January 2024.

Quiver AI Summary

IMAC Holdings, Inc. announced that it received a deficiency notification from Nasdaq on November 22, 2024, indicating non-compliance with Nasdaq Listing Rule 5250(c)(1) due to the late filing of its Quarterly Report on Form 10-Q for the period ending September 30, 2024. The Company is actively working to submit the report and has until January 21, 2024, to provide a plan for regaining compliance. If accepted, Nasdaq may grant an extension of up to 180 days to meet listing requirements. While the Company aims to address the issue promptly, there are no guarantees regarding compliance or avoiding potential delisting.

Potential Positives

  • The company is actively working to regain compliance with Nasdaq's listing rules and has a plan in place to do so within the specified timeline.
  • The deficiency notification does not have an immediate impact on the listing or trading of the company's common stock.
  • Nasdaq has the discretion to grant an extension of up to 180 days for the company to regain compliance, which shows potential for positive remediation options.

Potential Negatives

  • The company received a deficiency notification from Nasdaq due to its failure to timely file its Quarterly Report, which indicates potential financial reporting issues.
  • There is uncertainty regarding the company's ability to regain compliance with Nasdaq's listing rules within the allowed timeframe, which could lead to a delisting of its securities.
  • The failure to file the Form 10-Q could negatively impact investor confidence and the company's reputation in the market.

FAQ

What notification did IMAC Holdings receive from Nasdaq?

IMAC Holdings received a deficiency notification letter regarding non-compliance with Nasdaq Listing Rule 5250(c)(1) due to a late filing of its 10-Q.

What is the deadline for IMAC to submit a compliance plan?

IMAC has until January 21, 2024, to submit a plan to regain compliance with Nasdaq's listing rules.

How long could IMAC have to regain compliance if Nasdaq accepts its plan?

If accepted, Nasdaq may grant IMAC up to 180 days, until May 19, 2025, to regain compliance.

Will the listing of IMAC's common stock be affected immediately?

No, the deficiency notice has no immediate effect on the listing or trading of IMAC's common stock.

What happens if IMAC fails to regain compliance?

Failure to regain compliance may result in Nasdaq initiating delisting procedures for IMAC's securities.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


$BACK Hedge Fund Activity

We have seen 5 institutional investors add shares of $BACK stock to their portfolio, and 6 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • HRT FINANCIAL LP removed 51,862 shares (-100.0%) from their portfolio in Q2 2024
  • KESTRA ADVISORY SERVICES, LLC removed 44,395 shares (-100.0%) from their portfolio in Q3 2024
  • CITADEL ADVISORS LLC added 17,363 shares (+inf%) to their portfolio in Q3 2024
  • WALLEYE CAPITAL LLC removed 13,831 shares (-100.0%) from their portfolio in Q3 2024
  • GEODE CAPITAL MANAGEMENT, LLC added 11,642 shares (+inf%) to their portfolio in Q3 2024
  • TWO SIGMA SECURITIES, LLC added 11,545 shares (+inf%) to their portfolio in Q3 2024
  • TWO SIGMA INVESTMENTS, LP removed 11,379 shares (-100.0%) from their portfolio in Q2 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release



FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on November 22, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Form 10-Q"), as described more fully in the Company's Form 12b-25 Notification of Late Filing (the "Form 12b-25") filed with the Securities and Exchange Commission (the "SEC") on November 15, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.



The Company continues to work diligently to file the Form 10-Q as soon as practicable.



The Notice has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market.



The Company has until January 21, 2024, to submit a plan to regain compliance with the Listing Rule (the "Plan"). Pursuant to the Notice, if Nasdaq accepts the Plan, Nasdaq has the discretion to grant the Company an exception of up to 180 calendar days from the due date of the Form 10-Q, or until May 19, 2025, to regain compliance with the Listing Rule. The Company intends to take the necessary steps to regain compliance with Nasdaq's listing rules as soon as practicable.



While the Company can provide no assurances as to timing, the Company intends to take action to submit a plan to regain compliance within the 60 calendar day submission period, and, if Nasdaq accepts the plan to regain compliance, to subsequently regain compliance within the extended time granted by Nasdaq. While the Company is exercising diligent efforts to maintain the listing of its securities on the Nasdaq Capital Market, there can be no assurance that the Company will be able to regain compliance within the applicable time period. In addition, if the Company does not regain compliance within the applicable time period, Nasdaq could provide notice that the Company's securities will become subject to delisting. If the Company receives notice that its securities are being delisted, Nasdaq rules permit the Company to appeal any delisting determination by Nasdaq staff to a hearings panel.




About IMAC Holdings, Inc.



IMAC Holdings, Inc. is headquartered in Franklin, Tennessee. We operate our proteomic business through our nationally CLIA-certified, CAP-accredited and NY CLEP certified laboratory in Golden, Colorado.




Safe Harbor Statement



This document and the exhibits contain forward-looking statements within the meaning of Section 21E of the Exchange Act of 1934, as amended, which are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and expectations regarding the Company's filing of the Form 10-Q, statements relating to the Company's plan to regain compliance with Nasdaq's listing rules, as well as all statements that are not historical facts. These forward-looking statements are subject to change, and actual results may materially differ from those set forth in this Current Report due to certain risks and uncertainties. Factors that could cause or contribute to changes in such forward-looking statements include, but are not limited to, the risk that the completion and filing of the Form 10-Q will take longer than expected; uncertainties about the timing of the Company's submission of a compliance plan; Nasdaq's acceptance of any such plan; the duration of any extension that may be granted by Nasdaq; and the risk that the Company will be unable to meet Nasdaq's continued listing requirements. The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements set forth in reports filed with the SEC, including the Company's current reports on Form 8-K, quarterly reports on Form 10-Q and its annual report on Form 10-K/A, such as statements regarding changes in economic conditions and the impact of competition. Undue reliance should not be placed on any forward-looking statement contained herein. These statements reflect the Company's position as of the date of this Current Report. The Company expressly disclaims any undertaking to release publicly any updates or revisions to any statements to reflect any change in the Company's expectations or any change of events, conditions, or circumstances on which any such statement is based.




For additional information, please contact:





Investors@imacholdings.com




声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論